XtalPi raises $319m for AI based drug research and development
XtalPi, a pharma company that leverages artificial intelligence (AI) for drug discovery and development, has raised $318.8 million in a Series C round. The funding round was co-led by SoftBank Vision Fund 2i, PICC Capital, and Morningside. It saw the participation of more than 12 global investment firms in banking and technology, while existing investors […]